Archived

Content that has been automatically archived

New Logo, Address for CHA

This post has been archived and contains information that may be out of date.

CHA is pleased to show off our refreshed logo, and we have also updated our address.  

Cal/OSHA Approves Emergency Regulation on PPE Consumption, Issues FAQs

This post has been archived and contains information that may be out of date.

On June 8, Cal/OSHA submitted emergency regulations to the Office of Administrative Law to define “normal consumption.” As currently drafted, the emergency regulation defines “normal consumption” as the average consumption of specified personal protective equipment (PPE) type and size over a two- year period, with a 200% cap. This approach raises significant concerns, as CHA believes that this definition does not reflect statutory intent.  

Supreme Court Refuses to Hear Challenge to Site-Neutral Payment Policy for Clinic Visits

This post has been archived and contains information that may be out of date.

On Monday, the Supreme Court declined to hear the American Hospital Association’s challenge to the Centers for Medicare & Medicaid Services’ (CMS) calendar year (CY) 2019 site-neutral payment reduction when clinic visits are provided in off-campus hospital-based outpatient departments (HOPDs).  

UC Davis Health goes beyond hospital walls to vaccinate community

This post has been archived and contains information that may be out of date.

Without the help of university students, thousands of Sacramento’s most vulnerable residents might not have gotten COVID-19 vaccines. The University of California, Davis School of Medicine provided the workforce while UC Davis Health provided support.

HHHS Withdraws Guidance Requiring Manufacturers to Provide 340B Discount at Contract Pharmacies

This post has been archived and contains information that may be out of date.

This post has been archived and contains information that may be out of date.The Department of Health & Human Services (HHS) has withdrawn a December 2020 advisory opinion from the Health Resources and Services Administration requiring pharmaceutical manufacturers to sell covered entities 340B drugs at or below the ceiling price when those drugs are distributed through a contract pharmacy.  Earlier this year, AstraZeneca and other drugmakers sued the agency over the opinion. The withdrawal […]